IL-22 deficient mice exhibit aggravated experimental colitis following DSS exposure (109), and IL-22 orchestrates epithelial regeneration, proliferation and glycosylation, the production of mucins and anti-bacterial peptides and protects intestinal stem cells from genotoxic stress (36, 59–61, 63). The gene discussed is IL22; the disease is colitis.